The Pandemic Experience for People with Depressive Symptoms: Substance Use, Finances, Access to Treatment, and Trusted Sources of Information.

Autor: Sanchez K; Baylor Scott & White Research Institute, Dallas, TX, USA.; University of Texas at Arlington, School of Social Work, Arlington, TX, USA., da Graca B; Baylor Scott & White Research Institute, Dallas, TX, USA., Hall LR; Baylor Scott & White Research Institute, Dallas, TX, USA., Bennett MM; Baylor Scott & White Research Institute, Dallas, TX, USA., Powers MB; Baylor Scott & White Research Institute, Dallas, TX, USA.; Baylor University Medical Center, Dallas, TX, USA.; Texas A&M University-College of Medicine, Dallas, TX, USA., Warren AM; Baylor Scott & White Research Institute, Dallas, TX, USA.; Baylor University Medical Center, Dallas, TX, USA.; Texas A&M University-College of Medicine, Dallas, TX, USA.
Jazyk: angličtina
Zdroj: Substance abuse : research and treatment [Subst Abuse] 2022 Sep 27; Vol. 16, pp. 11782218221126973. Date of Electronic Publication: 2022 Sep 27 (Print Publication: 2022).
DOI: 10.1177/11782218221126973
Abstrakt: Background: Mental health impacts of the COVID-19 pandemic are well recognized, but little is known about the pandemic experience among people experiencing mental health symptoms.
Methods: In June 2020, a national sample of 5023 U.S. adults, including 785 scoring ⩾10 on the PHQ-8 for symptoms of depression, completed survey measures related to their pandemic experience.
Results: After adjusting for sociodemographic characteristics, aspects of the COVID-19 pandemic experience for which participants scoring PHQ-8 ⩾ 10 had the greatest increase in odds of reporting moderate/severe negative impacts included: mental health treatment access (odds ratio [OR], 95% confidence interval [CI] = 8.81, 6.70-11.57), family stress/discord (OR, 95% CI = 5.21, 4.24-6.42), food access (OR, 95% CI = 3.76, 2.97-4.77), and income/employment (OR, 95% CI = 3.19, 2.66-3.83). They were also significantly more likely to report increased use of prescription painkillers (OR, 95% CI = 8.46, 4.50-15.92) and other drugs (OR, 95% CI = 4.43, 2.85-6.89), and less trust in healthcare authorities/providers, family/friends, and employers, and more trust in websites/blogs/social media, for COVID-19 information ( P -values < .05).
Conclusions: The interplay among depressive symptoms, substance use, lack of trust in healthcare authorities, and negative impact of the pandemic on family, finances, and access to mental health treatment and food indicate the need for robust social and behavioral health safety nets to buffer communities from the shadow epidemics of depression, family violence, and overdose deaths during public health disasters.
Competing Interests: Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
(© The Author(s) 2022.)
Databáze: MEDLINE
Externí odkaz: